Clinical trial
Long-Term, Follow-Up Study Of the Safety And Efficacy Of Levetiracetam In…
NCT00152516 · UCB Pharma, Industry · Completed
Key facts
| NCT number | NCT00152516 |
|---|---|
| Title | Long-Term, Follow-Up Study Of the Safety And Efficacy Of Levetiracetam In Children With Partial Onset Seizures |
| Official title | A Multi-Center, Open-Label, Long-Term, Follow-Up Study Of the Safety And Efficacy Of Levetiracetam In Children With Partial Onset Seizures. |
| Lead sponsor | UCB Pharma, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Epilepsy, Partial |
| Intervention type | Drug |
| Interventions | levetiracetam (LEV) |
| Enrollment | 255 |
| Start date | Oct 1, 2004 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Sep 9, 2005 |
| Last update posted | Feb 12, 2013 |
| Countries | Belgium, Brazil, Canada, Czechia, France, Germany, Hungary, India, Italy, Mexico, Poland, Romania and 4 more |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: